Pharmacotherapy for Hoarding Disorder: How did the Picture Change since its Excision from OCD?


Journal

Current neuropharmacology
ISSN: 1875-6190
Titre abrégé: Curr Neuropharmacol
Pays: United Arab Emirates
ID NLM: 101157239

Informations de publication

Date de publication:
2019
Historique:
received: 26 10 2018
revised: 21 12 2018
accepted: 17 01 2019
pubmed: 27 1 2019
medline: 16 1 2020
entrez: 26 1 2019
Statut: ppublish

Résumé

This brief review deals with the various issues that contributed to the creation of the new Diagnostic and Statistical Manual condition of hoarding disorder (HD) and attempts at reviewing its pharmacotherapy. It appears that after the newly founded diagnosis appeared in the literature as an autonomous entity, distinct from obsessive-compulsive disorder, drug trials are not being conducted and the disorder is left in the hands of psychotherapists, who on their part, report fair results in some core dimensions of HD. The few trials on HD specifically regard the serotonin-noradrenaline reuptake inhibitor venlafaxine, and, possibly due to the suggestion of a common biological background of HD with attention-deficit/hyperactivity disorder, the psychostimulant methylphenidate and the noradrenaline reuptake inhibitor atomoxetine. For all these drugs, positive results have been reported, but the evidence level of these studies is low, due to small samples and non-blind designs. Regretfully, there are currently no future studies aiming at seriously testing drugs in HD.

Identifiants

pubmed: 30678629
pii: CN-EPUB-96088
doi: 10.2174/1570159X17666190124153048
pmc: PMC7059160
doi:

Substances chimiques

Serotonin Uptake Inhibitors 0
Methylphenidate 207ZZ9QZ49
Atomoxetine Hydrochloride 57WVB6I2W0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

808-815

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Références

Behav Res Ther. 2010 Oct;48(10):1012-20
pubmed: 20673573
PLoS One. 2018 Jul 16;13(7):e0200814
pubmed: 30011337
Int J Geriatr Psychiatry. 2013 Nov;28(11):1175-81
pubmed: 23440720
Depress Anxiety. 2013 Aug;30(8):741-8
pubmed: 23606213
Behav Res Ther. 2011 Oct;49(10):689-94
pubmed: 21784412
J Clin Psychiatry. 1998 Aug;59(8):420-5
pubmed: 9721822
Behav Res Ther. 1995 Nov;33(8):897-902
pubmed: 7487849
Psychiatry Res. 2014 Mar 30;215(3):659-67
pubmed: 24467873
J Clin Psychopharmacol. 2013 Jun;33(3):444-7
pubmed: 23609401
Drugs R D. 2018 Sep;18(3):167-189
pubmed: 30171515
Clin Psychol Rev. 2003 Dec;23(7):905-27
pubmed: 14624821
Australas Psychiatry. 2015 Aug;23(4):358-60
pubmed: 26019288
Aging Ment Health. 2016 Jul;20(7):736-42
pubmed: 25909628
Am J Psychiatry. 2008 Oct;165(10):1289-98
pubmed: 18483134
Braz J Psychiatry. 2007 Dec;29(4):303-7
pubmed: 18200396
Clin Psychol Rev. 2010 Jun;30(4):371-86
pubmed: 20189280
J Obsessive Compuls Relat Disord. 2013 Apr 1;2(2):130-136
pubmed: 23524977
Depress Anxiety. 2011 Oct 3;28(10):876-84
pubmed: 21770000
Compr Psychiatry. 2013 Apr;54(3):229-37
pubmed: 22995450
Psychol Med. 2013 Apr;43(4):837-47
pubmed: 22883395
J Clin Psychiatry. 2002 Jan;63(1):21-7
pubmed: 11838621
Behav Modif. 2001 Apr;25(2):214-32
pubmed: 11317635
Behav Res Ther. 2007 Apr;45(4):673-86
pubmed: 16824483
J Clin Psychiatry. 2010 Sep;71(9):1247-9
pubmed: 20923629
J Anxiety Disord. 2009 Jun;23(5):632-9
pubmed: 19261435
Psychiatry Res. 2014 Feb 28;221(2):142-8
pubmed: 24389161
Behav Res Ther. 1999 Sep;37(9):881-902
pubmed: 10458051
Neuropsychiatr Dis Treat. 2015 Apr 02;11:951-62
pubmed: 25897231
Behav Res Ther. 1996 Apr;34(4):341-50
pubmed: 8871366
Depress Anxiety. 2014 Dec;31(12):964-71
pubmed: 24277161
Asian J Psychiatr. 2017 Jun;27:53-66
pubmed: 28558897
Behav Res Ther. 2009 Jun;47(6):520-2
pubmed: 19296929
J Clin Psychiatry. 2011 Jun;72(6):780-6; quiz 878-9
pubmed: 21733479
Behav Res Ther. 2007 Jul;45(7):1461-70
pubmed: 17306221
Psychol Med. 2011 Dec;41(12):2475-84
pubmed: 21733224
N Engl J Med. 2014 May 22;370(21):2023-30
pubmed: 24849085
J Clin Psychopharmacol. 2001 Oct;21(5):488-92
pubmed: 11593074
J Affect Disord. 2006 Aug;94(1-3):199-209
pubmed: 16764938
Br J Psychiatry. 2013 Dec;203(6):445-52
pubmed: 24158881
Annu Rev Clin Psychol. 2012;8:219-42
pubmed: 22035242
PLoS One. 2017 Jun 28;12(6):e0179541
pubmed: 28658283
J Clin Psychiatry. 2001 Jul;62(7):535-40
pubmed: 11488364
Behav Res Ther. 1999 May;37(5):451-61
pubmed: 10228316
Compr Psychiatry. 2015 Feb;57:36-45
pubmed: 25483851
Psychiatry Res. 2016 Mar 30;237:138-46
pubmed: 26826899
Psychiatry Res. 2011 Oct 30;189(3):413-8
pubmed: 21764138
J Anxiety Disord. 2011 Mar;25(2):192-202
pubmed: 20934847
J Clin Psychiatry. 1999 Sep;60(9):591-7
pubmed: 10520977
J Psychiatr Res. 2007 Sep;41(6):481-7
pubmed: 16790250
J Psychiatr Res. 2016 Dec;83:240-248
pubmed: 27665536
Brain. 2005 Jan;128(Pt 1):201-12
pubmed: 15548551
Mol Psychiatry. 2014 Sep;19(9):1025-30
pubmed: 24912494
Int Clin Psychopharmacol. 2014 Sep;29(5):266-73
pubmed: 24722633
J Anxiety Disord. 2011 Jan;25(1):43-8
pubmed: 20800427
Child Dev. 1997 Feb;68(1):58-68
pubmed: 9084125
J Law Med. 2012 Dec;20(2):225-49
pubmed: 23431842
Behav Res Ther. 1996 Jan;34(1):47-51
pubmed: 8561764
Depress Anxiety. 2010 Jun;27(6):556-72
pubmed: 20336805
Am J Geriatr Psychiatry. 2015 Apr;23(4):416-422
pubmed: 24953872
Psychiatry Res. 2015 Sep 30;229(1-2):272-6
pubmed: 26213378
Am J Geriatr Psychiatry. 2014 Mar;22(3):248-52
pubmed: 23831173
Health Soc Care Community. 2019 May;27(3):517-530
pubmed: 30033635
Aust N Z J Psychiatry. 2008 Aug;42(8):651-61
pubmed: 18622773
Behav Res Ther. 2011 Feb;49(2):120-5
pubmed: 21193171
Psychiatry Res. 2017 Dec;258:221-225
pubmed: 28843626
J Clin Psychiatry. 2005 Dec;66(12):1517-23
pubmed: 16401151
Curr Psychiatry Rep. 2008 Aug;10(4):297-303
pubmed: 18627667
J Affect Disord. 2010 Feb;121(1-2):175-9
pubmed: 19577308
J Child Psychol Psychiatry. 2012 May;53(5):608-18
pubmed: 21895651
Depress Anxiety. 2010 May;27(5):476-84
pubmed: 20336804
Eur Neuropsychopharmacol. 2008 Jun;18(6):455-61
pubmed: 18353618
CNS Spectr. 2008 Jun;13(6):492-8
pubmed: 18567973
Behav Modif. 1996 Jan;20(1):116-32
pubmed: 8561769
Depress Anxiety. 2010 Jun;27(6):528-55
pubmed: 20533367

Auteurs

Daria Piacentino (D)

Neurosciences, Mental Health, and Sensory Organs (NESMOS) Department, School of Medicine and Psychology, Sapienza University, Rome, Italy.
Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism (NIAAA) Division of Intramural Clinical and Basic Research and National Institute on Drug Abuse (NIDA) Intramural Research Program, National Institutes of Health, Bethesda, MD, United States.

Massimo Pasquini (M)

Department of Neurosciences, School of Medicine and Dentistry, Sapienza University, Rome, Italy.

Simone Cappelletti (S)

Anatomical, Histological, Forensic Medicine, and Orthopedic Sciences (SAIMLAL) Department, Sapienza University, Rome, Italy.

Chiara Chetoni (C)

Neurosciences, Mental Health, and Sensory Organs (NESMOS) Department, School of Medicine and Psychology, Sapienza University, Rome, Italy.

Gabriele Sani (G)

Neurosciences, Mental Health, and Sensory Organs (NESMOS) Department, School of Medicine and Psychology, Sapienza University, Rome, Italy.

Georgios D Kotzalidis (GD)

Neurosciences, Mental Health, and Sensory Organs (NESMOS) Department, School of Medicine and Psychology, Sapienza University, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH